allylamine has been researched along with Colorectal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, G; Dhiman, A; Guchhait, P; Gupta, A; Shrimali, N; Singhmar, R; Sood, A | 1 |
1 other study(ies) available for allylamine and Colorectal Neoplasms
| Article | Year |
|---|---|
Redox responsive poly(allylamine)/eudragit S-100 nanoparticles for dual drug delivery in colorectal cancer.
Topics: Allylamine; Animals; Colorectal Neoplasms; Curcumin; Doxorubicin; Mice; Nanoparticles; Oxidation-Reduction; Tissue Distribution | 2022 |